InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Davis Blaine, 首席财务官. Director active across 2 companies, notably Protara Therapeutics, Inc.. In total, 7 filings have been recorded. Split: 0 buy · 2 sells. Total volume traded: €126k. Activity tracked since 3 January 2022. The latest transaction was filed on 6 January 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Davis Blaine is Chief Financial Officer and has 7 filings in total. Among the 7 sampled recent filings between 2022-01-05 and 2026-01-08, the sell volume is EUR 126159 and the transaction nature shown is Attribution. His filings concern Cartesian Therapeutics, Inc. and Protara Therapeutics, Inc.